Moreover, a recent study by Smit et al. [49] indicated that mutations in the APC, TP53, KRAS, and SMAD4 genes, all characteristics for colorectal adenoma-carcinoma transition, are associated with enhanced global translational capacity, which may, at least in part, counterbalance the reduced transcription observed here. This evidence concerns the gene KRAS and carcinoma.